Dr. Fan is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
303 E 60th St
Apt 15C
New York, NY 10022Phone+1 212-826-0731
Education & Training
- Memorial Sloan Kettering Cancer CenterFellowship, Hematology and Medical Oncology, 2004 - 2010
- New York Presbyterian Hospital (Cornell Campus)Residency, Internal Medicine, 2001 - 2004
- Columbia University Vagelos College of Physicians and SurgeonsClass of 2001
Certifications & Licensure
- NY State Medical License 2003 - 2022
Publications & Presentations
PubMed
- Patritumab deruxtecan in HER2-negative breast cancer: part B results of the window-of-opportunity SOLTI-1805 TOT-HER3 trial and biological determinants of early response.Fara Brasó-Maristany, Juan Manuel Ferrero-Cafiero, Claudette Falato, Olga Martínez-Sáez, Juan Miguel Cejalvo
Nature Communications. 2024-07-11 - 12 citationsHERTHENA-Lung02: phase III study of patritumab deruxtecan in advanced-mutated NSCLC after a third-generation EGFR TKI.Tony Mok, Pasi A Jänne, Makoto Nishio, Silvia Novello, Martin Reck
Future Oncology. 2024-05-01 - 50 citationsHERTHENA-Lung01, a Phase II Trial of Patritumab Deruxtecan (HER3-DXd) in Epidermal Growth Factor Receptor-Mutated Non-Small-Cell Lung Cancer After Epidermal Growth Fac...Helena A Yu, Yasushi Goto, Hidetoshi Hayashi, Enriqueta Felip, James Chih-Hsin Yang
Journal of Clinical Oncology. 2023-12-10
Professional Memberships
- Member
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: